GIM
BIS icon

Guild Investment Management’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Guild Investment Management’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-875
Closed -$270K – 14
2015
Q3 		$270K Buy
+875
New +$206K 0.6% 12

Other funds holding BIS

HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAM
Chesapeake Asset Management New York $126M AUM 36.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

Guild Investment Management's BIS Position: Q4 2015 in Review

Guild Investment Management sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q4 2015, closing a stake of 875 shares — an estimated $270K sold.

Guild Investment Management first reported a position in BIS in Q3 2015 and held it in 1 quarter. The position peaked at $270K in Q3 2015. 15 funds tracked by Wall St. Rank hold BIS as of Q4 2015.

  • Guild Investment Management reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q4 2015 after selling out during the quarter.
  • Guild Investment Management sold 875 ProShares UltraShort NASDAQ Biotechnology shares in Q4 2015, an estimated $270K.
  • Guild Investment Management first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q3 2015 and held it in 1 quarter.
  • Guild Investment Management's ProShares UltraShort NASDAQ Biotechnology position peaked at $270K in Q3 2015.
  • 15 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q4 2015.

Based on Guild Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.